BioCryst Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
Okay, it's my pleasure to introduce our first presenter, Jon Stonehouse from -- Chief Executive Officer of BioCryst, to give us a brief introduction, and then we will have a Q&A session.
Good morning. Thank you, Gena, for the introduction and inviting us to your health care conference. With me today is our Chief Commercial Officer, Lynne Powell; and our Head of Investor Relations, John Bluth. And they'll be joining me in the Q&A session.
So as Gena said, I'll be giving just a quick overview of the company and our programs, but we'll spend the bulk of the time going through question-and-answer with Gena and, hopefully, questions from the audience.
So really exciting time to be a part of BioCryst, and there's a lot of activity going on. 2019 is a big year for us with some important milestones, and I look forward to sharing the progress we're making and our plans for the year. I'll be
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |